Frank Moosig

Summary

Publications

  1. ncbi [Autoimmune vasculitides. Standards and guidelines of EULAR and EUVAS]
    F Moosig
    Klinikum Bad Bramstedt und Poliklinik für Rheumatologie, Universitatsklinikum Schleswig Holstein, Oskar Alexander Strasse 26, 24576, Bad Bramstedt, Deutschland
    Internist (Berl) 50:298-309. 2009
  2. ncbi [Infectious pulmonary complications of rheumatic diseases]
    F Moosig
    Klinikum Bad Bramstedt, Klinik für Rheumatologie und Klinische Immunologie, Poliklinik fur Rheumatologie, Universitatsklinikum Schleswig Holstein, Bad Bramstedt, Deutschland
    Z Rheumatol 68:658-64. 2009
  3. ncbi Value of anti-infective chemoprophylaxis in primary systemic vasculitis: what is the evidence?
    Frank Moosig
    Department of Rheumatology, University Hospital of Schleswig Holstein and Klinikum Bad Bramstedt, Oskar Alexander Str, 26, 24576 Bad Bramstedt, Germany
    Arthritis Res Ther 11:253. 2009
  4. ncbi Diagnostic and therapeutic management of Churg-Strauss syndrome
    Julia U Holle
    University Hospital Schleswig Holstein, Campus Luebeck, Dept of Rheumatology and Klinikum Bad Bramstedt, Dept of Rheumatology and Immunology, Oskar Alexander Strasse 26, 24576 Bad, Bramstedt, Germany
    Expert Rev Clin Immunol 5:813-23. 2009
  5. ncbi Distinct proteinase 3-induced cytokine patterns in Wegener´s granulomatosis, Churg-Strauss syndrome, and healthy controls
    Ursula Fagin
    University of Lubeck, Department of Rheumatology, Vasculitis Center UKSH and Clinical Center Bad Bramstedt, Lubeck, Germany
    Clin Exp Rheumatol 29:S57-62. 2011

Detail Information

Publications5

  1. ncbi [Autoimmune vasculitides. Standards and guidelines of EULAR and EUVAS]
    F Moosig
    Klinikum Bad Bramstedt und Poliklinik für Rheumatologie, Universitatsklinikum Schleswig Holstein, Oskar Alexander Strasse 26, 24576, Bad Bramstedt, Deutschland
    Internist (Berl) 50:298-309. 2009
    ..Refractory disease should be treated within clinical trails. Further recommendations deal with monitoring of diseases activity and therapy as well as with measures to avoid complications and late sequelae...
  2. ncbi [Infectious pulmonary complications of rheumatic diseases]
    F Moosig
    Klinikum Bad Bramstedt, Klinik für Rheumatologie und Klinische Immunologie, Poliklinik fur Rheumatologie, Universitatsklinikum Schleswig Holstein, Bad Bramstedt, Deutschland
    Z Rheumatol 68:658-64. 2009
    ..There is evidence in favour of PCP prophylaxis with trimethoprim/cotrimoxazole in patients receiving intense immunosuppression with high dose glucocorticoids and cyclophosphamide...
  3. ncbi Value of anti-infective chemoprophylaxis in primary systemic vasculitis: what is the evidence?
    Frank Moosig
    Department of Rheumatology, University Hospital of Schleswig Holstein and Klinikum Bad Bramstedt, Oskar Alexander Str, 26, 24576 Bad Bramstedt, Germany
    Arthritis Res Ther 11:253. 2009
    ..The only prophylactic measure that is widely accepted is trimethoprim/sulfamethoxazole to avoid Pneumocystis jiroveci pneumonia in small vessel vasculitis patients with generalised disease receiving therapy for induction of remission...
  4. ncbi Diagnostic and therapeutic management of Churg-Strauss syndrome
    Julia U Holle
    University Hospital Schleswig Holstein, Campus Luebeck, Dept of Rheumatology and Klinikum Bad Bramstedt, Dept of Rheumatology and Immunology, Oskar Alexander Strasse 26, 24576 Bad, Bramstedt, Germany
    Expert Rev Clin Immunol 5:813-23. 2009
    ..g., cyclophosphamide for life-threatening disease) are usually required. Future promising therapy options target cytokines involved in the disease process, such as IL-5...
  5. ncbi Distinct proteinase 3-induced cytokine patterns in Wegener´s granulomatosis, Churg-Strauss syndrome, and healthy controls
    Ursula Fagin
    University of Lubeck, Department of Rheumatology, Vasculitis Center UKSH and Clinical Center Bad Bramstedt, Lubeck, Germany
    Clin Exp Rheumatol 29:S57-62. 2011
    ..To analyse whether a specific cytokine pattern is elicited in response to the autoantigen proteinase 3 (PR3) in active Wegener's granulomatosis (WG)...